Silo Pharma, Inc. (SILO) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SILO Revenue Growth
SILO Revenue Analysis (2013–2024)
As of May 8, 2026, Silo Pharma, Inc. (SILO) generated trailing twelve-month (TTM) revenue of $72,102, reflecting slight decline in growth of +0.0% year-over-year. The most recent quarter (Q3 2025) recorded $18,025 in revenue, up 0.0% sequentially.
Looking at the longer-term picture, SILO's 5-year compound annual growth rate (CAGR) stands at +12.2%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $847,407 in 2017.
When compared to Healthcare sector peers including ATAI (+811.8% YoY), and PSTV (-10.5% YoY), SILO has underperformed the peer group in terms of revenue growth. Compare SILO vs ATAI →
SILO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SILOCurrent | $72,102 | +0.0% | +12.2% | -6526.4% | |
 ATAI | $308,000 | +811.8% | - | -33341.2% | |
 PSTV | $5M | -10.5% | +76.7% | -293.5% |
SILO Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $72K | +0.0% | $66K | 91.9% | $-4,705,694 | -6526.4% |
| 2023 | $72K | +0.0% | $66K | 91.9% | $-3,855,592 | -5347.4% |
| 2022 | $72K | +1.2% | $66K | 91.9% | $-3,627,656 | -5031.3% |
| 2021 | $71K | - | $66K | 93.0% | $-2,744,343 | -3851.0% |
| 2020 | $0 | -100.0% | $0 | - | $-2,201,719 | - |
| 2019 | $41K | - | $13K | 32.5% | $-930,403 | -2293.4% |
| 2018 | $0 | -100.0% | $-17,550 | - | $-594,242 | - |
| 2017 | $847K | +226.6% | $847K | 100.0% | $-470,388 | -55.5% |
| 2016 | $-669,480 | -361.1% | $-669,480 | 100.0% | $-393,658 | 58.8% |
| 2015 | $-145,185 | -35.5% | $-145,185 | 100.0% | $-217,172 | 149.6% |
See SILO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SILO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SILO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSILO — Frequently Asked Questions
Quick answers to the most common questions about buying SILO stock.
Is SILO's revenue growth accelerating or slowing?
SILO TTM revenue: $72102.00. YoY growth: +0.0%. 5-year CAGR: +12.2%.
What is SILO's long-term revenue growth rate?
Silo Pharma, Inc.'s 5-year revenue CAGR of +12.2% reflects the variable expansion pattern. Current YoY growth of +0.0% is near this long-term average.
How is SILO's revenue distributed by segment?
SILO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.